# HYDRALAZINE HYDROCHLORIDE

NDC: 43066-041
Generic name: HYDRALAZINE HYDROCHLORIDE
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20250717

FDA application: ANDA219797

## Active ingredients

- HYDRALAZINE HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-041"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-041
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1a10203-f027-4f9c-8dd6-907c6db24d47